Observation series — 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
109 observation(s) recorded. 109 carry an address; none is without one. 108 retained normalised text and hold a digest. 1 hold none: 1 where a server answered and no response body was recorded; and none was hashed.
Each observation is addressed by this row’s identifier, the date it was observed, and its sequence within that date — the same key /api/v1/series.jsonl publishes as `sequence`, counted in the order the store recorded them.
This digest is a leaf of the integrity root, and the command that recomputes it is published at /verify.
Every addressed record below carries its own citation, naming the day, the URL that answered, the response as recorded, and the digest where one exists. Where none exists the citation says so and asserts no digest.
| Address | Date | Outcome | Method | Normalised text | SHA-256 of normalised text |
|---|---|---|---|---|---|
2026-07-31·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-07-31·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-07-31 (record 1 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-07-31-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-07-31·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-07-31·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-07-31 (record 2 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-07-31-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-07-31·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-07-31·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-07-31 (record 3 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-07-31-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-07-31·4 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-07-31·4
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-07-31 (record 4 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-07-31-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-07-31·5 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-07-31·5
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-07-31 (record 5 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-07-31-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-01·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-01·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-01 (record 1 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-01-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-01·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-01·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-01 (record 2 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-01-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-01·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-01·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-01 (record 3 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-01-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-02·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-02·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-02 (record 1 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02 — the day this
observation was recorded, UTC.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-02-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-02·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-02·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-02 (record 2 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02 — the day this
observation was recorded, UTC.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-02-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-02·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-02·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-02 (record 3 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02 — the day this
observation was recorded, UTC.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-02-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-03·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-03·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-03 (record 1 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-03-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-03·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-03·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-03 (record 2 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-03-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-03·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-03·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-03 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-03-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-04·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-04·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-04 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-04-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-04·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-04·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-04 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-04-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-05·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-05·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-05 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-05-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-05·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-05·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-05 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-05-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-05·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-05·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-05 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-05-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-06·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-06·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-06 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-06 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-06-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-06·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-06·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-06 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-06 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-06-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-07·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-07·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-07 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-07 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-07-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 393b48f902b837662950a1aec5bca642ec0dc2b1487d5dec104ccd6373b451fa | |
2026-08-08·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-08·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-08 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-08-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned · content changed | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-08·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-08·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-08 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-08-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-08·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-08·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-08 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-08-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-08·4 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-08·4
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-08 (record 4 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-08-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·4 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·4
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 4 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·5 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·5
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 5 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·6 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·6
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 6 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·7 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·7
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 7 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-7
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-09·8 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-09·8
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-09 (record 8 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-09-8
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-10·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-10·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-10 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-10-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-10·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-10·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-10 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-10-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-10·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-10·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-10 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-10-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-10·4 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-10·4
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-10 (record 4 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-10-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-10·5 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-10·5
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-10 (record 5 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-10-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-10·6 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-10·6
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-10 (record 6 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-11 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-10-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-11·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-11·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-11 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-11 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-11-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-11·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-11·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-11 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-11-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-11·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-11·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-11 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-11-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·4 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·4
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 4 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·5 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·5
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 5 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·6 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·6
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 6 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·7 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·7
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 7 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-7
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·8 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·8
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 8 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-8
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-12·9 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-12·9
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-12 (record 9 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-12-9
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-13·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-13·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-13 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-13 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-13-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 5997ebbb66615f64b6eeee4e643bbae371cfa262fa2aae4b19645508b3189561 | |
2026-08-14·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-14·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-14 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-14 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-14-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned · content changed | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-15·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-15·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-15 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-15-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-15·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-15·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-15 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-15-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-15·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-15·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-15 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-15-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-16·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-16·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-16 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-16-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-16·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-16·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-16 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-16-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-16·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-16·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-16 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-16-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-16·4 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-16·4
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-16 (record 4 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-16-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-17·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-17·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-17 (record 1 of that day)
Requested: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(no answering URL was recorded for this observation)
Response: HTTP 500, fetched blocked, no response body was recorded
Digest: NONE RECORDED. No response body was recorded, and no normalised
text was retained for this observation, so nothing was hashed.
This citation asserts no digest.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-17 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-17-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 500 · no response body recorded · HTTP 500 | blocked | — | a server answered and no response body was recorded, so nothing was hashed | |
2026-08-18·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-18·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-18 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-18 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-18-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 9d7b6d9aa4e134c40e14f458fc10130b2c105e71fd482694c63a306dc77f1d43 | |
2026-08-19·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-19·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-19 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 18e04a0c925a01486357077898c82ba38eb236f8f4423a2071952465e827a0d8
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-19 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-19-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned · content changed | direct | 88,643 chars | 18e04a0c925a01486357077898c82ba38eb236f8f4423a2071952465e827a0d8 | |
2026-08-20·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-20·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-20 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 18e04a0c925a01486357077898c82ba38eb236f8f4423a2071952465e827a0d8
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-20 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-20-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 18e04a0c925a01486357077898c82ba38eb236f8f4423a2071952465e827a0d8 | |
2026-08-21·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-21·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-21 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-21 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-21-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned · content changed | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-22·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-22·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-22 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-22 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-22-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-22·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-22·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-22 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-22 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-22-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-23·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-23·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-23 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-23 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-23-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-24·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-24·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-24 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-24 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-24-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-25·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-25·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-25 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-25 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-25-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-25·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-25·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-25 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-25 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-25-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-26·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-26·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-26 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-26 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-26-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-26·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-26·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-26 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-26 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-26-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-27·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-27·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-27 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-27 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-27-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | 1e7f136841292df1484cbe2668c3f941f7005a63539be671db5cdb831bd57a59 | |
2026-08-28·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-28·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-28 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 f24b92ecdf425f86f463835a80a86142c45308ee43cdba5c7d6f64d4845bf23d
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-28 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-28-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned · content changed | direct | 88,643 chars | f24b92ecdf425f86f463835a80a86142c45308ee43cdba5c7d6f64d4845bf23d | |
2026-08-29·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-29·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-29 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-29 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-29-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned · content changed | direct | 88,643 chars | b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d | |
2026-08-29·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-29·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-29 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-29 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-29-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d | |
2026-08-30·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-30·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-30 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-30 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-30-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d | |
2026-08-30·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-30·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-30 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,656 bytes returned
Digest: SHA-256 b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d
88,643 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-30 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-30-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,656 bytes returned | direct | 88,643 chars | b670ac9656b7eed06935ddab3e5382672dccf4d4f2f00bfa9c04815bd83c606d | |
2026-08-31·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-08-31·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-08-31 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,728 bytes returned
Digest: SHA-256 bc527e48bcd825107e370b161505f7b4b261a1fdfe8cd71be2cedd70b1572971
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-08-31 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-08-31-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,728 bytes returned · content changed | direct | 88,711 chars | bc527e48bcd825107e370b161505f7b4b261a1fdfe8cd71be2cedd70b1572971 | |
2026-09-01·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-01·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-01 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 bc527e48bcd825107e370b161505f7b4b261a1fdfe8cd71be2cedd70b1572971
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-01 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-01-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | bc527e48bcd825107e370b161505f7b4b261a1fdfe8cd71be2cedd70b1572971 | |
2026-09-02·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-02·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-02 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-02-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned · content changed | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-02·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-02·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-02 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-02-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-03·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-03·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-03 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-03-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-04·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-04·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-04 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-04-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-04·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-04·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-04 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-04-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·2 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·2
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 2 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·3 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·3
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 3 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·4 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·4
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 4 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·5 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·5
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 5 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·6 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·6
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 6 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·7 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·7
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 7 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-7
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·8 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·8
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 8 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-8
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-05·9 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-05·9
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-05 (record 9 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-05-9
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-06·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-06·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-06 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-06 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-06-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-07·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-07·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-07 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb
88,711 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-07 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-07-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 88,711 chars | 4edb9480421c24ce478d141081e716451837cc2dcdb0771da63b85912af7e0eb | |
2026-09-08·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-08·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-08 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-08-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned · content changed | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-09·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-09·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-09 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-09-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-10·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-10·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-10 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-10-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-11·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-11·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-11 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-11 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-11-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-12·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-12·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-12 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-12-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-13·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-13·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-13 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-13 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-13-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-14·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-14·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-14 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-14 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-14-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-15·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-15·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-15 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-15-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-16·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-16·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-16 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-16-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-17·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-17·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-17 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-17 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-17-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c | |
2026-09-18·1 Cite this observationGxPlex observation record us-21-cfr-part-211 2026-09-18·1
Document: 21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
Observed: 2026-09-18 (record 1 of that day)
Answered at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
Response: HTTP 200, fetched direct, 270,737 bytes returned
Digest: SHA-256 cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c
87,662 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260802111521/https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
(Internet Archive, submitted 2026-08-02, before this observation
was recorded on 2026-09-18 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/us-21-cfr-part-211#obs-2026-09-18-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 270,737 bytes returned | direct | 87,662 chars | cd3e1c0c936b59ded15e4c38e27a38b03e2e1d8b6a00fd2c82629696dd6a103c |
Every record above is published untruncated at /api/v1/series.jsonl,
which carries the same sequence these addresses are built
from.